Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00308399 · ClinicalTrials.gov registry record · Phase 2
A Study to Evaluate the Effect of a Medicine on Gastric Functions in Healthy Volunteers.
A Phase 2 study, sponsored by Mayo Clinic.
- Completed
- Registry status
- Phase 2
- Development phase
- 45
- Enrollment target
NCT00308399: Completed Phase 2 study, sponsored by Mayo Clinic.
NCT00308399 is a Phase 2 study that has completed, run by Mayo Clinic. The registered enrollment target is 45 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00308399, a Phase 2 study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 45 participants
- Enrollment target
Study Summary
A 7 day study which involves 2 nutrient drink tests, an ECG, a Scintigraphy scan, and a Sect scan. This study requires the participant to make 4 visits to the GCRC in the Charlton building but no overnight stays.
Interventions
- DRUG Itopride
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2005-11 |
| Est. Completion | 2007-06 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00308399
The ClinicalTrials.gov registry entry for NCT00308399 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Itopride is the first listed.
NCT00308399 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00308399 about?
NCT00308399 is a clinical study titled "A Study to Evaluate the Effect of a Medicine on Gastric Functions in Healthy Volunteers.". A 7 day study which involves 2 nutrient drink tests, an ECG, a Scintigraphy scan, and a Sect scan. This study requires the participant to make 4 visits to the GCRC in the Charlton building but no overnight stays.
What is the current status of trial NCT00308399?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 45 participants. The study started on 2005-11. Estimated completion is 2007-06.
What interventions are being tested in trial NCT00308399?
The interventions under investigation include: Itopride (DRUG).
Who is sponsoring clinical trial NCT00308399?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.